10 December 2022 in Nature Communications
Small multidrug resistance (SMR) transporters contribute to antibiotic resistance through proton-coupled efflux of toxic compounds. Previous biophysical studies of the E. coli SMR transporter EmrE suggest that it should also be able to perform proton/toxin symport or uniport, leading to toxin susceptibility rather than resistance in vivo. Here we show EmrE does confer susceptibility to several previously uncharacterized small-molecule substrates in E. coli, including harmane. In vitro electrophysiology assays demonstrate that harmane binding triggers uncoupled proton flux through EmrE. Assays in E. coli are consistent with EmrE-mediated dissipation of the transmembrane pH gradient as the mechanism underlying the in vivo phenotype of harmane susceptibility. Furthermore, checkerboard assays show this alternative EmrE transport mode can synergize with some existing antibiotics, such as kanamycin. These results demonstrate that it is possible to not just inhibit multidrug efflux, but to activate alternative transport modes detrimental to bacteria, suggesting a strategy to address antibiotic resistance.
25 April 2023 in Journal of the American Chemical Society
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
3 September 2025 in Biochemistry
The recent discovery that the model multidrug efflux pump from Escherichia coli, EmrE, can perform multiple types of transport suggests that this may be a compelling target for therapeutic intervention. Initial studies have identified several small-molecule substrates capable of inducing transporter-dependent susceptibility rather than the well-known antibiotic resistance phenotype. However, many questions regarding the underlying mechanism and regulation of this transporter still remain. Prior studies identified lysine 22 as well as threonine 56 as important residues for regulating the formation of an occluded state critical to the prevention of an uncoupled leak in the WT transporter. Here, we use NMR chemical shift perturbations and in vivo EC50 assays to confirm that 18-crown-6-ether binds at lysine 22, while liposomal leak assays verify that this substrate triggers uncoupled proton leak. In addition to characterizing the mechanism of action of another susceptibility substrate for EmrE, the characterization of K22 mutants herein solidifies the importance of this residue, as well as the nearby residue T56, in the allosteric regulation of the C-terminal tail. With a high degree of familial conservation in addition to a suggested role in transporter evolution, mechanistic insight into the transport regulation of EmrE may be broadly applicable across small multidrug-resistant efflux pumps.